APH Buy and Sells Today

Anonymous Now On The Sell

14 ITG	6,360	75,101	11.808	256,944	3,014,171	11.731	-250,584	2,939,070
1 Anonymous	1,101,487	12,935,060	11.743	1,447,526	16,989,718	11.737	-346,039	4,054,658
TOTAL	4,419,964	51,914,233	11.745	4,419,964	51,914,233	11.745	0	0

014 ITG Canada Corp And Anonymous  Big Sellers 

House #14 ITG (which is system for institutional traders NOT RETAIL)

Investment Technology Group (NYSE: ITG) is a global financial technology company that helps leading brokers and asset managers improve returns for investors around the world. We empower traders to reduce the end-to-end cost of implementing investments via technology-enabled liquidity, execution, analytics and workflow solutions. ITG has offices in Asia Pacific, Europe and North America and offers execution services in more than 50 countries. 
Read more at http://www.stockhouse.com/companies/bullboard/t.aph/aphria-inc?postid=28099177#zZLBRHwiROQOsHDI.99

House Positions for C:APH from 20180530 to 20180530

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
7 TD Sec	568,002	6,663,773	11.732	369,091	4,341,102	11.762	198,911	-2,322,671
15 UBS	145,745	1,709,979	11.733	2,500	29,100	11.64	143,245	-1,680,879
89 Raymond James	137,198	1,610,194	11.736	8,601	101,282	11.776	128,597	-1,508,912
85 Scotia	272,788	3,200,396	11.732	146,490	1,727,349	11.792	126,298	-1,473,047
2 RBC	319,317	3,755,342	11.761	256,862	3,018,334	11.751	62,455	-737,008
124 Questrade	101,911	1,196,671	11.742	53,773	632,546	11.763	48,138	-564,125
8 Eight	50,000	589,800	11.796	7,200	84,960	11.80	42,800	-504,840
80 National Bank	78,998	927,158	11.736	49,445	580,831	11.747	29,553	-346,327
39 Merrill Lynch	166,129	1,951,076	11.744	139,039	1,632,308	11.74	27,090	-318,768
24 Clarus	25,000	293,250	11.73	0			25,000	-293,250
22 Fidelity	30,245	353,586	11.691	16,565	195,262	11.788	13,680	-158,324
99 Jitney	61,600	724,434	11.76	55,500	652,673	11.76	6,100	-71,761
58 Qtrade	14,609	171,077	11.71	10,055	117,860	11.722	4,554	-53,217
74 GMP	3,000	35,250	11.75	0			3,000	-35,250
70 Manulife	2,530	29,919	11.826	0			2,530	-29,919
59 PI	2,200	25,897	11.771	0			2,200	-25,897
57 Interactive	2,035	24,010	11.799	180	2,107	11.706	1,855	-21,903
36 Latimer	3,912	45,872	11.726	2,679	31,441	11.736	1,233	-14,431
56 Edward Jones	1,042	12,223	11.73	0			1,042	-12,223
94 Hampton	1,000	11,750	11.75	0			1,000	-11,750
28 BBS	14,930	174,680	11.70	14,400	168,565	11.706	530	-6,115
68 Leede	100	1,169	11.69	0			100	-1,169
79 CIBC	716,327	8,419,029	11.753	716,547	8,416,003	11.745	-220	-3,026
83 Mackie	0			700	8,183	11.69	-700	8,183
13 Instinet	115,402	1,355,374	11.745	116,749	1,369,992	11.735	-1,347	14,618
88 Credential	1,845	21,588	11.701	3,200	37,598	11.749	-1,355	16,010
19 Desjardins	48,581	571,828	11.771	50,920	600,716	11.797	-2,339	28,888
72 Credit Suisse	6,477	76,877	11.869	11,300	132,681	11.742	-4,823	55,804
143 Pershing	11,074	130,061	11.745	17,893	210,917	11.788	-6,819	80,856
76 Industrial Alliance	123	1,457	11.846	10,000	118,499	11.85	-9,877	117,042
90 Barclays	0			11,200	131,311	11.724	-11,200	131,311
65 Goldman	1,500	17,534	11.689	17,400	204,197	11.735	-15,900	186,663
53 Morgan Stanley	13,895	162,679	11.708	35,003	410,268	11.721	-21,108	247,589
33 Canaccord	199,800	2,347,675	11.75	266,855	3,130,322	11.73	-67,055	782,647
9 BMO Nesbitt	194,802	2,292,464	11.768	325,347	3,823,937	11.753	-130,545	1,531,473
14 ITG	6,360	75,101	11.808	256,944	3,014,171	11.731	-250,584	2,939,070
1 Anonymous	1,101,487	12,935,060	11.743	1,447,526	16,989,718	11.737	-346,039	4,054,658
TOTAL	4,419,964	51,914,233	11.745	4,419,964	51,914,233	11.745	0	0

Aphria picked by Canaccord Target $25.50

Canaccord Genuity Research Analyst Matt Bottomley is very focused on the Cannabis sector in both the United States and Canada. But recent moves b y U.S. politicians has him unabashedly excited about Canadian cannabis companies with U.S. operations.
Aphria Inc (TSXV: APH), the Healthcare company, was revisited by a Wall Street analyst today. Analyst Matt Bottomley from Canaccord Genuity reiterated a Buy rating, with a C$25.50 price target.

James West:  Sure. What would be your favorite Canadian company that has boots on the ground international and is going to get a big chunk of the Canadian market share?

Matt Bottomley: For me, it’s Aphria. The reason for that is it checks all those boxes. I think when you look at the volatility in the market, when you look at the absolute valuation of the top-tier groups, when I say that I mean by infrastructure build, by market capitalization, by current run rates, they really are jockeying for position. By all means, I think Canopy is probably the leader in the space when it comes to its ultimate size and scale and how it’s been able to brand itself already as I think anecdotally when I talk to people entrenched in the industry, everyone knows the Tweed name.

With an Aphria, you’re getting that same exposure at one-third the valuation, and I love the relative valuation on it. I think they probably have the best international exposure with their recent acquisition of Nuuvera. I fully expect, and I don’t know if Ontario’s going to release their purchase orders specifically as Quebec did; where they sort of said here’s our top six and here are the numbers but I fully expect Aphria and the Aphria’s of the world, similar competitors to get very large chunks of those markets too.

James West:  Okay, so Aphria is making some pretty aggressive moves with the acquisition of Nuuvera, etc., are there any other Canadian companies are really worthy of paying attention to for the investors that have the potential to make big moves internationally?

Click Here For Full Interview

Aphria Inc (TSXV: APH), the Healthcare company, was revisited by a Wall Street analyst today. Analyst Matt Bottomley from Canaccord Genuity reiterated a Buy rating, with a C$25.50 price target.

According to TipRanks.com, Bottomley is ranked #261 out of 4778 analysts.

Read also: Check-Cap (CHEK): Shoring Up the Balance Sheet by Selling Shares Comes with a Price

Currently, the analyst consensus on Aphria Inc is Moderate Buy and the average price target is C$25.38, representing a 158.7% upside.

In a report issued on April 24, Clarus also maintained a Buy rating on the stock with a C$25.25 price target.

Aphria, Inc. engages in the production and supply of medical marijuana. Its products include alien dawg, champlian indica, grower’s blend, champlain-sativa and blueberry. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.

Report On $25.50 Target